Albrich et al developed a risk classification for patients with lower respiratory tract infections based on the CURB65 and serum levels of proadrenomedullin. The patient's risk category can help guide management. The authors are from the University of Basel.
Patient selection: adult >= 59 years old with lower respiratory tract infection (community-acquired pneumonia, other)
Parameters:
(1) CURB65 score
(2) admission serum proadrenomedullin (proADM) concentration
CURB65 |
proADM < 0.75 nmol/L |
proADM 0.75 to 1.5 nmol/L |
proADM > 1.5 nmol/L |
0 or 1 |
low (I) |
intermediate (II) |
high (III) |
2 |
intermediate (II) |
intermediate (II) |
high (III) |
3 to 5 |
high (III) |
high (III) |
high (III) |
The patient is high risk if CURB65 is >= 3 OR proADM > 1.5 nmol/L.
The patient is low risk if CURB65 <= 1 AND proADM < 0.75 nmol/L.
All other patients are intermediate risk.
Risk Group |
Management |
low (I) |
outpatient treatment |
intermediate (II) |
short hospital stay |
high (III) |
hospital stay based on severity |
Limitation:
• Classification depends on accurate measurement of the proadrenomedullin concentration.
Specialty: Infectious Diseases, Pulmonology
ICD-10: ,